Production (Stage)
Universal Ibogaine Inc.
IBOGF
$0.018
-$0.0003-1.64%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.07M | -1.66M | -1.61M | -1.51M | -1.15M |
| Total Depreciation and Amortization | 249.30K | 252.00K | 249.90K | 252.70K | 247.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 519.40K | 789.90K | 800.60K | 805.10K | 391.00K |
| Change in Net Operating Assets | -161.40K | -137.40K | -104.20K | -167.90K | -35.00K |
| Cash from Operations | -461.60K | -753.30K | -661.90K | -617.60K | -551.30K |
| Capital Expenditure | -15.10K | -29.30K | -36.10K | -57.70K | -56.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -15.10K | -29.30K | -36.10K | -57.70K | -56.10K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -218.50K | -218.70K | -219.00K | -225.30K | -131.90K |
| Issuance of Common Stock | 220.00K | 1.21M | 1.53M | 1.63M | 1.41M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 319.60K | -10.90K | -429.90K | -429.90K | -337.20K |
| Cash from Financing | 225.20K | 711.90K | 650.50K | 719.30K | 694.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -251.50K | -70.80K | -47.50K | 44.00K | 86.70K |